Noveome Biotherapeutics earns FDA designations for new biologic application

Pittsburgh-based Noveome Biotherapeutics Inc. has earned two designations from the U.S. Food and Drug Administration for a new potential application of its biologic product ST266.
Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.